CN Patent

CN103705942A — 抗微生物组合物

Assigned to Melita LLC · Expires 2014-04-09 · 12y expired

What this patent protects

本发明涉及抗微生物组合物且更特别地涉及喹诺酮羧酸衍生物的组合物。这些组合物具有改善的溶解度、稳定性和耐受性。这些组合物用于静脉内施用，以治疗感染、预防感染或降低感染的风险。

USPTO Abstract

本发明涉及抗微生物组合物且更特别地涉及喹诺酮羧酸衍生物的组合物。这些组合物具有改善的溶解度、稳定性和耐受性。这些组合物用于静脉内施用，以治疗感染、预防感染或降低感染的风险。

Drugs covered by this patent

delafloxacin-meglumine (DELAFLOXACIN MEGLUMINE)

Patent Metadata

Patent number: CN103705942A
Jurisdiction: CN
Classification: —
Expires: 2014-04-09
Drug substance claim: No
Drug product claim: No
Assignee: Melita LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.